Micro-Invasive Glaucoma Surgery (MIGS)

iStent inject®

Your Once-In-A-Lifetime Opportunity to Treat Glaucoma & Cataracts at the Same Time

If you’ve been managing your glaucoma symptoms with medication, and now are preparing for cataract surgery, iStent inject® may be an ideal option for you. Around the world, iStent inject® has helped people with glaucoma successfully manage their intraocular pressure. By taking advantage of this once-in-a-lifetime opportunity during cataract surgery, you can help address both of these conditions at the same time.

Open Your Eyes to a World of Possibilities

• With iStent inject®, most patients are able to maintain normal eye pressure after the procedure
• iStent inject® has an excellent safety profile, similar to cataract surgery alone

If you think you may be a candidate for iStent inject®, talk to your eye care professional today to find out if iStent inject® is right for you.

The treatment for glaucoma has come a long way. Today’s advanced technologies and procedures make it possible to diagnose and successfully manage this progressive disease. And while the overall goal of treatment has always remained the same — reducing intraocular pressure (IOP) and glaucomatous progression — Micro-Invasive Glaucoma Surgery (MIGS) is quickly becoming a widely accepted approach for treating mild-to-moderate glaucoma.

Glaucoma Therapy Advances

Glaucoma is primarily managed with prescription eye drops. If a patient’s glaucoma progresses or the patient stops responding to the eye drops, a surgical solution is offered. These surgical solutions are often highly invasive, require long recovery times, and could result in long-term complications.

As technology has progressed, less invasive techniques have emerged that have improved the safety profile for glaucoma surgery. This opened more surgical options for patients interested in effective glaucoma management which does not rely solely on the continuous use of prescription medication.

A Revolution in Glaucoma Therapy

With the FDA approval of the iStent®, Micro-Invasive Glaucoma Surgery (MIGS) became a preferred approach to glaucoma management for many eye care professionals and their patients with mild-to-moderate glaucoma.

Now, with the FDA approval of iStent inject® – the next-generation Glaukos trabecular micro-bypass technology – Glaukos is advancing the standard of care for glaucoma patients.

Performed at the time of cataract surgery, iStent inject® has proven to be effective in decreasing IOP, with an excellent safety profile, few complications, and fast recovery time.

iStent inject® may also reduce patients’ need for medications as determined by an eye care professional. The majority of patients who received iStent inject® in the U.S. pivotal trial were medication-free at 23 months. Other benefits associated with this innovative treatment include:

• Minimally traumatic to delicate eye tissue
• Effectively lowers IOP
• Excellent safety profile
• Rapid recovery

To help control the increased pressure in your eye associated with glaucoma, iStent inject® creates two bypasses, or openings, between the front part of your eye and its natural drainage pathway to increase the flow of fluid. By creating the permanent bypasses through the primary blockage site (trabecular meshwork), iStent inject® is designed to:

• Improve your eye’s natural outflow to safely lower intraocular pressure
• Work continuously to improve the natural flow of fluid in your eyes

You should continue to use any prescribed eye drops until your procedure, unless directed by your eye care professional. Before surgery, your eye surgeon will go over all the medications you’re currently taking. Be sure to bring a list of your current medications to your pre-operative appointment and be prepared to answer a few questions regarding your medical history.

The cataract removal and iStent inject® procedure are usually performed under local anesthesia. After your surgeon removes your cataracts, he or she will implant the iStent inject® devices. Once implanted, you will not see or feel the devices.

iStent inject® is an outpatient procedure, which means you’ll be able to go home the same day following your surgery. After the procedure, you will likely receive antibiotic and anti-inflammatory eye drops to use. Your ophthalmologist will likely schedule an appointment to see you the day following the surgery.

Recovery time is usually quick, but your doctor may recommend that you take a few days off work. You should also refrain from strenuous activities such as sports, lifting heavy objects, or any straining movements that will increase your eye pressure.

The risks associated with performing cataract surgery with the iStent inject® are similar to those related to performing cataract surgery alone. For more information regarding specific risks associated with your condition, please talk to your eye care professional

Contact Information

 

Address: Suite 7B, 34 Lady Musgrave Road, Kgn 5

Tel: (876) 630-0958; 630-0864; 759-6449

Email: ophthalmicsuites@gmail.com 

Doctors

 

Dr. Maynard McIntosh

Dr. Romea Mitchell

Dr. Sherwin Benskin

Dr. Draya Leon Garrido

Dr. Jeffery Zimm

Dr. Miguel Lopez

Dr. Frine Salazar 

 

 

Contact Us